EXPERIMENTAL STUDY
The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model
Moto-o Date, MD, PhD*,
Takashi Morita, MD ,
Nobushige Yamashita, MD, PhD*,
Kazuhiko Nishida, MD, PhD,
Osamu Yamaguchi, MD*,
Yoshiharu Higuchi, MD*,
Shinichi Hirotani, MD,
Yasushi Matsumura, MD, PhD ,
Masatsugu Hori, MD, PhD, FACC*,
Michihiko Tada, MD, PhD, FACC and
Kinya Otsu, MD, PhD*,*
* Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Osaka, Japan
Department of Pathophysiology, Osaka University Graduate School of Medicine, Osaka, Japan
Department of Medical Information Science, Osaka University Graduate School of Medicine, Osaka, Japan
Manuscript received August 7, 2001;
revised manuscript received November 19, 2001,
accepted December 6, 2001.
* Reprint requests and correspondence: Dr. Kinya Otsu, Department of Pathophysiology, Box H2, Osaka University Graduate School of Medicine, Suita 565-0871, Japan.
kotsu{at}medone.med.osaka-u.ac.jp
OBJECTIVES: In order to identify the role of reactive oxygen species (ROS) in cardiac hypertrophy, we examined the effect of N-2-mercaptopropionyl glycine (MPG) on cardiac hypertrophy.
BACKGROUND: Recent in vitro studies have suggested that ROS play an important role as a second messenger in cardiac hypertrophy. It was therefore thought to be of particular value to examine the relevance of studies using in vitro models for cardiac hypertrophy in an in vivo setting.
METHODS: The transverse thoracic aorta in mice was constricted, and MPG (100 mg/kg) was infused intraperitoneally twice daily. The animals were assessed seven days after the operation for hemodynamic functions, oxidative stress and antioxidative enzyme activities.
RESULTS: Banding of the transverse aorta in mice resulted in an increase in the ratio of heart weight to tibia length and the appearance of an endogenous atrial natriuretic factor messenger ribonucleic acid (mRNA) seven days postoperatively. Administration of MPG significantly attenuated the hypertrophic responses induced by pressure overload. Cardiac hypertrophy was accompanied by increases in heme oxygenase-1 mRNA expression and lipid peroxidation, which was eliminated by the treatment with MPG. Pressure overload led to increases in antioxidant enzyme activities, such as superoxide dismutase and glutathione peroxidase, but not catalase, activity.
CONCLUSIONS: Our results indicated that oxidative stress was increased in our model and that it plays an important role in the development of cardiac hypertrophy.
|
Abbreviations and Acronyms
| | GSHPx | | ANF | | atrial natriuretic factor | | GSHPx | | glutathione peroxidase | | HO-1 | | heme oxygenase-1 | | MDA | | malonaldehyde | | MPG | | N-2-mercaptopropionyl glycine | | ROS | | reactive oxygen species | | SOD | | superoxide dismutase | | TAC | | transverse thoracic aorta constriction |
|
This article has been cited by other articles:
|
|
|
|
 
D.-F. Dai, L. F. Santana, M. Vermulst, D. M. Tomazela, M. J. Emond, M. J. MacCoss, K. Gollahon, G. M. Martin, L. A. Loeb, W. C. Ladiges, et al.
Overexpression of Catalase Targeted to Mitochondria Attenuates Murine Cardiac Aging
Circulation,
June 2, 2009;
119(21):
2789 - 2797.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. R. Brunt, M. R. Tsuji, J. H. Lai, R. T. Kinobe, W. Durante, W. C. Claycomb, C. A. Ward, and L. G. Melo
Heme Oxygenase-1 Inhibits Pro-Oxidant Induced Hypertrophy in HL-1 Cardiomyocytes
Experimental Biology and Medicine,
May 1, 2009;
234(5):
582 - 594.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Hori and K. Nishida
Oxidative stress and left ventricular remodelling after myocardial infarction
Cardiovasc Res,
February 15, 2009;
81(3):
457 - 464.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Redout, M. J. Wagner, M. J. Zuidwijk, C. Boer, R. J.P. Musters, C. van Hardeveld, W. J. Paulus, and W. S. Simonides
Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species
Cardiovasc Res,
September 1, 2007;
75(4):
770 - 781.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Juric, P. Wojciechowski, D. K. Das, and T. Netticadan
Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol
Am J Physiol Heart Circ Physiol,
May 1, 2007;
292(5):
H2138 - H2143.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Takimoto and D. A. Kass
Role of Oxidative Stress in Cardiac Hypertrophy and Remodeling
Hypertension,
February 1, 2007;
49(2):
241 - 248.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Joo, M. Kim, V. D. D'Agati, and H. T. Lee
Ischemic Preconditioning Provides Both Acute and Delayed Protection against Renal Ischemia and Reperfusion Injury in Mice
J. Am. Soc. Nephrol.,
November 1, 2006;
17(11):
3115 - 3123.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Laskowski, O. L. Woodman, A. H. Cao, G. R. Drummond, T. Marshall, D. M. Kaye, and R. H. Ritchie
Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes
Cardiovasc Res,
October 1, 2006;
72(1):
112 - 123.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. E. Murdoch, M. Zhang, A. C. Cave, and A. M. Shah
NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure
Cardiovasc Res,
July 15, 2006;
71(2):
208 - 215.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Liao, S. Takashima, H. Zhao, Y. Asano, Y. Shintani, T. Minamino, J. Kim, M. Fujita, M. Hori, and M. Kitakaze
Control of plasma glucose with alpha-glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice
Cardiovasc Res,
April 1, 2006;
70(1):
107 - 116.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Cave, D. Grieve, S. Johar, M. Zhang, and A. M Shah
NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology
Phil Trans R Soc B,
December 29, 2005;
360(1464):
2327 - 2334.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-C. Battista, E. Calvo, A. Chorvatova, B. Comte, J. Corbeil, and M. Brochu
Intra-uterine growth restriction and the programming of left ventricular remodelling in female rats
J. Physiol.,
May 15, 2005;
565(1):
197 - 205.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Tsujimoto, S. Hikoso, O. Yamaguchi, K. Kashiwase, A. Nakai, T. Takeda, T. Watanabe, M. Taniike, Y. Matsumura, K. Nishida, et al.
The Antioxidant Edaravone Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy
Hypertension,
May 1, 2005;
45(5):
921 - 926.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Kuster, E. Kotlyar, M. K. Rude, D. A. Siwik, R. Liao, W. S. Colucci, and F. Sam
Mineralocorticoid Receptor Inhibition Ameliorates the Transition to Myocardial Failure and Decreases Oxidative Stress and Inflammation in Mice With Chronic Pressure Overload
Circulation,
February 1, 2005;
111(4):
420 - 427.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Nishida, O. Yamaguchi, S. Hirotani, S. Hikoso, Y. Higuchi, T. Watanabe, T. Takeda, S. Osuka, T. Morita, G. Kondoh, et al.
p38{alpha} Mitogen-Activated Protein Kinase Plays a Critical Role in Cardiomyocyte Survival but Not in Cardiac Hypertrophic Growth in Response to Pressure Overload
Mol. Cell. Biol.,
December 15, 2004;
24(24):
10611 - 10620.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. E Hardt and J. Sadoshima
Negative regulators of cardiac hypertrophy
Cardiovasc Res,
August 15, 2004;
63(3):
500 - 509.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Yoshioka, P. C. Schulze, M. Cupesi, J. D. Sylvan, C. MacGillivray, J. Gannon, H. Huang, and R. T. Lee
Thioredoxin-Interacting Protein Controls Cardiac Hypertrophy Through Regulation of Thioredoxin Activity
Circulation,
June 1, 2004;
109(21):
2581 - 2586.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Maytin, D. A. Siwik, M. Ito, L. Xiao, D. B. Sawyer, R. Liao, and W. S. Colucci
Pressure Overload-Induced Myocardial Hypertrophy in Mice Does Not Require gp91phox
Circulation,
March 9, 2004;
109(9):
1168 - 1171.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Yamaguchi, Y. Higuchi, S. Hirotani, K. Kashiwase, H. Nakayama, S. Hikoso, T. Takeda, T. Watanabe, M. Asahi, M. Taniike, et al.
Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling
PNAS,
December 23, 2003;
100(26):
15883 - 15888.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Aravamudan, D. Volonte, R. Ramani, E. Gursoy, M. P. Lisanti, B. London, and F. Galbiati
Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype
Hum. Mol. Genet.,
November 1, 2003;
12(21):
2777 - 2788.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Byrne,*, D. J. Grieve, J. K. Bendall, J.-M. Li, C. Gove, J. D. Lambeth, A. C. Cave, and A. M. Shah
Contrasting Roles of NADPH Oxidase Isoforms in Pressure-Overload Versus Angiotensin II-Induced Cardiac Hypertrophy
Circ. Res.,
October 31, 2003;
93(9):
802 - 805.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
